Skip to main content
HIMS
NYSE Life Sciences

Hims' Partner to Reintroduce Controversial GLP-1 Pill After Regulatory Halt

Tom Rudovsky · Reported by Reuters
More coverage: Household Product Stocks · Consumer
Sentiment info
Neutral
Importance info
8
Price
$15.53
Mkt Cap
$3.54B
52W Low
$13.74
52W High
$70.43
52W Position info
13% above low
Off High info
78% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

HIMS is trading near its 52-week low of $13.74 (13% above the low) on light trading volume (0.4× avg).

Summary

Hims & Hers Health's pharmacy partner, Strive Pharmacy, plans to resume sales of its compounded GLP-1 weight-loss pill, which was previously pulled from the market due to U.S. regulatory pushback. This development follows Hims' earlier announcement of offering a low-cost compounded semaglutide, a move that drew significant criticism from Novo Nordisk and an FDA referral to the Department of Justice. While the reintroduction signals Hims' intent to continue pursuing the lucrative weight-loss market, Strive Pharmacy has not yet set a firm timeline, indicating ongoing caution. This is a material update for Hims' product strategy and competitive positioning, but the persistent regulatory risks, including the DOJ referral, remain a significant overhang.

At the time of this announcement, HIMS was trading at $15.53 on NYSE in the Life Sciences sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $13.74 to $70.43. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

HIMS - Latest Insights

HIMS
Nov 11, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $19.00
Real-time Price: $15.13 info
Change: -$3.87 (-20%) info
Market Cap: $3.422B info
HIMS
Nov 10, 2026, 1:54 PM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $18.85
Real-time Price: $15.13 info
Change: -$3.71 (-20%) info
Market Cap: $3.422B info
HIMS
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $22.16
Real-time Price: $15.13 info
Change: -$7.03 (-32%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 5:52 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.33
Real-time Price: $15.13 info
Change: -$7.20 (-32%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.39
Real-time Price: $15.13 info
Change: -$8.26 (-35%) info
Market Cap: $3.422B info